These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16138857)

  • 1. Synthesis and evaluation of peptidic metal chelators for neuroprotection in neurodegenerative diseases.
    Zheng H; Youdim MB; Weiner LM; Fridkin M
    J Pept Res; 2005 Oct; 66(4):190-203. PubMed ID: 16138857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases.
    Zheng H; Weiner LM; Bar-Am O; Epsztejn S; Cabantchik ZI; Warshawsky A; Youdim MB; Fridkin M
    Bioorg Med Chem; 2005 Feb; 13(3):773-83. PubMed ID: 15653345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel potential neuroprotective agents with both iron chelating and amino acid-based derivatives targeting central nervous system neurons.
    Zheng H; Youdim MB; Weiner LM; Fridkin M
    Biochem Pharmacol; 2005 Nov; 70(11):1642-52. PubMed ID: 16226724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition.
    Zheng H; Gal S; Weiner LM; Bar-Am O; Warshawsky A; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):68-78. PubMed ID: 16181413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron: a new target for pharmacological intervention in neurodegenerative diseases.
    Whitnall M; Richardson DR
    Semin Pediatr Neurol; 2006 Sep; 13(3):186-97. PubMed ID: 17101458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and examination of neuron protective properties of alkenylated and amidated dehydro-silybin derivatives.
    Yang LX; Huang KX; Li HB; Gong JX; Wang F; Feng YB; Tao QF; Wu YH; Li XK; Wu XM; Zeng S; Spencer S; Zhao Y; Qu J
    J Med Chem; 2009 Dec; 52(23):7732-52. PubMed ID: 19673490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane permeability of redox active metal chelators: an important element in reducing hydroxyl radical induced NAD+ depletion in neuronal cells.
    Jayasena T; Grant RS; Keerthisinghe N; Solaja I; Smythe GA
    Neurosci Res; 2007 Mar; 57(3):454-61. PubMed ID: 17210195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heteroarylnitrones as drugs for neurodegenerative diseases: synthesis, neuroprotective properties, and free radical scavenger properties.
    Porcal W; Hernández P; González M; Ferreira A; Olea-Azar C; Cerecetto H; Castro A
    J Med Chem; 2008 Oct; 51(19):6150-9. PubMed ID: 18788732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential application of iron chelators for the treatment of neurodegenerative diseases.
    Hider RC; Roy S; Ma YM; Le Kong X; Preston J
    Metallomics; 2011 Mar; 3(3):239-49. PubMed ID: 21344071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
    Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
    J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chelating agents for neurodegenerative diseases.
    Ward RJ; Dexter DT; Crichton RR
    Curr Med Chem; 2012; 19(17):2760-72. PubMed ID: 22489724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chelators on mercury, iron, and lead neurotoxicity in cortical culture.
    Rush T; Hjelmhaug J; Lobner D
    Neurotoxicology; 2009 Jan; 30(1):47-51. PubMed ID: 19027035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel neuroprotective neurotrophic NAP analogs targeting metal toxicity and oxidative stress: potential candidates for the control of neurodegenerative diseases.
    Zheng H; Blat D; Fridkin M
    J Neural Transm Suppl; 2006; (71):163-72. PubMed ID: 17447427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective role for carbonyl reductase?
    Maser E
    Biochem Biophys Res Commun; 2006 Feb; 340(4):1019-22. PubMed ID: 16406002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of cyclo-phen-type ligands: chelators of metal ions as potential therapeutic agents in the treatment of neurodegenerative diseases.
    Boldron C; Van der Auwera I; Deraeve C; Gornitzka H; Wera S; Pitié M; Van Leuven F; Meunier B
    Chembiochem; 2005 Nov; 6(11):1976-80. PubMed ID: 16208731
    [No Abstract]   [Full Text] [Related]  

  • 16. Metal ions, Alzheimer's disease and chelation therapy.
    Budimir A
    Acta Pharm; 2011 Mar; 61(1):1-14. PubMed ID: 21406339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against hydrogen peroxide-mediated cytotoxicity in Friedreich's ataxia fibroblasts using novel iron chelators of the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone class.
    Lim CK; Kalinowski DS; Richardson DR
    Mol Pharmacol; 2008 Jul; 74(1):225-35. PubMed ID: 18424550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuroprotective effect of Activin A and B: implication for neurodegenerative diseases.
    Kupershmidt L; Amit T; Bar-Am O; Youdim MB; Blumenfeld Z
    J Neurochem; 2007 Nov; 103(3):962-71. PubMed ID: 17680997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orally Bioavailable Metal Chelators and Radical Scavengers: Multifunctional Antioxidants for the Coadjutant Treatment of Neurodegenerative Diseases.
    Kawada H; Kador PF
    J Med Chem; 2015 Nov; 58(22):8796-805. PubMed ID: 26068053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiparkinson drug--Mucuna pruriens shows antioxidant and metal chelating activity.
    Dhanasekaran M; Tharakan B; Manyam BV
    Phytother Res; 2008 Jan; 22(1):6-11. PubMed ID: 18064727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.